1. Home
  2. QUBT vs OCUP Comparison

QUBT vs OCUP Comparison

Compare QUBT & OCUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QUBT
  • OCUP
  • Stock Information
  • Founded
  • QUBT 2001
  • OCUP 2018
  • Country
  • QUBT United States
  • OCUP United States
  • Employees
  • QUBT N/A
  • OCUP N/A
  • Industry
  • QUBT Computer Manufacturing
  • OCUP Biotechnology: Pharmaceutical Preparations
  • Sector
  • QUBT Technology
  • OCUP Health Care
  • Exchange
  • QUBT Nasdaq
  • OCUP Nasdaq
  • Market Cap
  • QUBT 54.1M
  • OCUP 53.1M
  • IPO Year
  • QUBT N/A
  • OCUP N/A
  • Fundamental
  • Price
  • QUBT $0.69
  • OCUP $1.22
  • Analyst Decision
  • QUBT Strong Buy
  • OCUP Strong Buy
  • Analyst Count
  • QUBT 1
  • OCUP 3
  • Target Price
  • QUBT $8.75
  • OCUP $18.67
  • AVG Volume (30 Days)
  • QUBT 416.4K
  • OCUP 96.2K
  • Earning Date
  • QUBT 11-11-2024
  • OCUP 11-11-2024
  • Dividend Yield
  • QUBT N/A
  • OCUP N/A
  • EPS Growth
  • QUBT N/A
  • OCUP N/A
  • EPS
  • QUBT N/A
  • OCUP N/A
  • Revenue
  • QUBT $335,047.00
  • OCUP $16,449,000.00
  • Revenue This Year
  • QUBT $184.88
  • OCUP N/A
  • Revenue Next Year
  • QUBT $150.00
  • OCUP $258.69
  • P/E Ratio
  • QUBT N/A
  • OCUP N/A
  • Revenue Growth
  • QUBT 23.21
  • OCUP N/A
  • 52 Week Low
  • QUBT $0.36
  • OCUP $1.15
  • 52 Week High
  • QUBT $1.32
  • OCUP $3.40
  • Technical
  • Relative Strength Index (RSI)
  • QUBT 53.67
  • OCUP 40.68
  • Support Level
  • QUBT $0.65
  • OCUP $1.24
  • Resistance Level
  • QUBT $0.77
  • OCUP $1.39
  • Average True Range (ATR)
  • QUBT 0.04
  • OCUP 0.07
  • MACD
  • QUBT 0.00
  • OCUP -0.00
  • Stochastic Oscillator
  • QUBT 40.15
  • OCUP 4.76

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an American company utilizing non-linear quantum optics (optical devices whose output due to quantum effects is exponentially, not linearly, related to inputs) to deliver quantum products for high-performance computing applications. QCi's products are designed to operate at room temperature and use low power at an affordable cost. The Company's portfolio of core technology and products offer new capabilities in the areas of high-performance computing, artificial intelligence, cyber security as well as remote sensing applications.

About OCUP Ocuphire Pharma Inc.

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.

Share on Social Networks: